S. Ansell
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 7
-
- T-cell and Retrovirus Studies 1
-
- Chronic Lymphocytic Leukemia Research 3
- Dermatology top 10%
-
- Lung Cancer Treatments and Mutations 2
-
- Advanced Radiotherapy Techniques 2
-
- PI3K/AKT/mTOR signaling in cancer 1
-
- Acute Myeloid Leukemia Research 1
-
- Medical Imaging Techniques and Applications 1
S. Ansell
12 papers receiving 347 citations
Peers
Comparison fields: 5 of 57
- Pathology and Forensic Medicine 167
- Immunology 162
- Oncology 158
- Genetics 58
- Dermatology 38
Countries citing papers authored by S. Ansell
This map shows the geographic impact of S. Ansell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Ansell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Ansell more than expected).
Fields of papers citing papers by S. Ansell
This network shows the impact of papers produced by S. Ansell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Ansell. The network helps show where S. Ansell may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. Ansell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 1 | |
| 2 | 2016 | 35 | |
| 3 | CHECKMATE 205: A PHASE 2 STUDY OF NIVOLUMAB IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION AND BRENTUXIMAB VEDOTIN | 2016 | 3 |
| 4 | CHECKMATE 205 COHORT C: NIVOLUMAB IN PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA AFTER PRIOR BRENTUXIMAB VEDOTIN AND AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION | 2016 | 1 |
| 5 | 2015 | 79 | |
| 6 | 2012 | 21 | |
| 7 | 2009 | 0 | |
| 8 | 2008 | 8 | |
| 9 | 2008 | 2 | |
| 10 | 2007 | 23 | |
| 11 | 2002 | 46 | |
| 12 | 1997 | 112 | |
| 13 | 1992 | 21 |
About S. Ansell
S. Ansell is a scholar working on Pathology and Forensic Medicine, Genetics and Radiation, having authored 13 papers that have together received 352 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Chronic Lymphocytic Leukemia Research (3 papers), Lung Cancer Treatments and Mutations (2 papers), Advanced Radiotherapy Techniques (2 papers), PI3K/AKT/mTOR signaling in cancer (1 paper), Acute Myeloid Leukemia Research (1 paper), T-cell and Retrovirus Studies (1 paper) and Medical Imaging Techniques and Applications (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (167 citations), Immunology (162 citations) and Oncology (158 citations). S. Ansell has collaborated with scholars based in United States, Canada and Poland. Frequent co-authors include Thomas M. Habermann, Paul J. Kurtin, C Y Li, David J. Inwards, Thomas E. Witzig, Joseph P. Colgan, Anne J. Novak, TE Witzig, Steven C. Ziesmer and Michael P. Gustafson. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and Medical Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.